← All trials
NCT06657066
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 6, 2021
- Primary completion
- Apr 24, 2022
- Completion date
- Aug 8, 2023
- First posted
- Oct 24, 2024
- Last posted
- Oct 24, 2024
- Enrollment
- 74
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- King Edward Medical UniversityLead sponsor
- King Edward Medical UniversitySponsor investigator
- King Edward Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.